
Daniel J Lovell MD
Professor, Pediatrics, University of Cincinnati College of Medicine
Join to view full profile
3333 Burnet Ave# 4010Cincinnati, OH 45229
Phone+1 513-636-7686
Fax+1 513-636-5568
Dr. Lovell is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineFellowship, Rheumatology, 1982 - 1984
University of Texas School of Public HealthM.P.H., Biostatistics/Study Design, 1982 - 1984
Children’s Mercy HospitalResidency, Pediatrics, 1978 - 1981
University of Kansas School of MedicineClass of 1978
University of KansasB.A., Philosophy, 1969 - 1975
Certifications & Licensure
OH State Medical License 1984 - 2028
KY State Medical License 2021 - 2027
IN State Medical License 2024 - 2025
TN State Medical License 2024 - 2025
FL State Medical License 2015 - 2017
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Rheumatology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Innovative Educator Award American College of Rheumatology, 2007
- Distinguished Clinical Investigator American College of Rheumatology, 2007
Clinical Trials
Publications & Presentations
PubMed
- Impact of tofacitinib on growth in patients with juvenile idiopathic arthritis.Hermine I Brunner, Mittermayer Santiago, Beth Gottlieb, Sheila K Oliveira, Pooja Patel
Annals of the Rheumatic Diseases. 2026-09-01 - Development and validation of minimal disease activity, disease flare, and minimal clinically important difference for children with chronic nonbacterial osteomyelitis...Farzana Nuruzzaman, Natalie Rosenwaser, Xing Wang, Jonathan D Akikusa, Matthew L Basiaga
Annals of the Rheumatic Diseases. 2026-08-08 - Pharmacokinetics, Effectiveness and Safety of Certolizumab Pegol in Children and Adolescents With Active Juvenile Idiopathic Arthritis: 9+-Year Results From a Multicen...Hermine I Brunner, Lyudmila Grebenkina, Irina Nikishina, Ekaterina Alexeeva, Vyacheslav Chasnyk
Arthritis & Rheumatology. 2026-07-13
Journal Articles
- Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016Hermine I Brunner, Melissa L Mannion, Judyann C Olson, Vibeke Strand, Daniel J Lovell, Meredith P Riebschleger, Susan Shenoi, Journal of Rheumatology
- Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trialOddis CV, Reed AM, Aggarwal R, Rider LG, Ascherman DP, Levesque MC, Barohn RJ, Feldman BM, Harris-Love MO, Koontz DC, Fertig N, Kelley SS, Pryber SL, Miller FW, Rocket..., Arthritis Rheum, 2/1/2013
- American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritisWallace CA, Giannini EH, Huang B, Itert L, Ruperto N; Childhood Arthritis Rheumatology Research Alliance; Pediatric Rheumatology Collaborative Study Group; Paediatric ..., Arthritis Care Res, 7/1/2011
Books/Book Chapters
Abstracts/Posters
- The long-term safety of etanercept in children with polyarticular or systemic juvenile rheumatoid arthritisGiannini EH, Ilowite NT, Lovell DJ, et al, Proceeding of the 14th Pediatric Rheumatology European Society Rheumatology Congress, 1/1/2007
- Efficacy and safety of abatacept in children and adolescents with active juvenile idiopathic arthritis (JIA): Results of double-blind withdrawal phaseBlock AJ, Ruperto N, Lovell DJ, Giannini EH, Martini A, Rheumatology, 1/1/2007
- The long-term safety of etanercept in children with polyarticular or systemic juvenile rheumatoid arthritisGiannini EH, Ilowite NT, Lovell DJ, et al, Annals of Rheumatic Diseases, 1/1/2007
Press Mentions
Clinician Roundtable: Experts Discuss Barriers in JIA Management and Measures to Improve OutcomesJuly 11th, 2025- Changing Treatment Patterns for Patients with JIAOctober 18th, 2022
- Updated Pediatric Uveitis Recommendations Advise on Expanded Treatment OptionsJune 16th, 2022
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: